Evidence map›Paper›PMID 30449321›Full record

ArticleStem cell reports2018

Genetic Engineering of Human Embryonic Stem Cells for Precise Cell Fate Tracing during Human Lineage Development.

Zhenyu Chen, Xudong Ren, Xiangjie Xu, Xiaojie Zhang, Yi Hui, Zhongliang Liu, Lei Shi, Yujiang Fang, Lin Ma, Yang Liu and 3 more

Erratum issuedAbstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Uncovering the role of FOXA2 in the Development of Human Serotonin Neurons.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Building Blocks of Artificial CRISPR-Based Systems beyond Nucleases.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Zhenyu ChenBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Xudong RenBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Xiangjie XuBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Xiaojie ZhangBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Yi HuiBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Zhongliang LiuBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Lei ShiBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Yujiang FangBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Lin MaBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Yang LiuBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Daniel Terheyden-KeighleyBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China.
Ling LiuBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Reconstruction and Regeneration of Spine and Spinal Cord Injury, Ministry of Education, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China. Electronic address: lliu@tongji.edu.cn.
Xiaoqing ZhangBrain and Spinal Cord Innovative Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; Key Laboratory of Reconstruction and Regeneration of Spine and Spinal Cord Injury, Ministry of Education, Shanghai, China; Key Laboratory of Neuroregeneration of Shanghai Universities, Tongji University School of Medicine, Shanghai, China. Electronic address: xqzhang@tongji.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is highly desirable to specify human developmental principles in an appropriate human model with advanced genetic tools. However, genetically engineering human cells with lineage-tracing systems has not been achieved. Here we introduce strategies to construct lineage-tracing systems in human embryonic stem cells (hESCs). The AAVS1 locus was suitable for the integration of the conditional reporter. The Cre-LoxP and Flp-FRT systems were highly sensitive, which may cause inaccurate lineage labeling in human cells. The recombination sensitivity and tracing fidelity could be finely tuned by modification of the LoxP recombination site. Moreover, tamoxifen-controllable Cre

Indexed as

Cell LineageGenetic EngineeringAnimalsBase SequenceCell LineEctodermGenetic LociHuman Embryonic Stem CellsHumansIntegrasesMice, Inbred NODMice, SCIDMutationNeural Stem CellsPAX6 Transcription FactorRecombinant Fusion ProteinsCre recombinaseIntegrasesPAX6 Transcription FactorRecombinant Fusion ProteinsdevelopmentFOXA2genetic engineeringhuman embryonic stem cellslineage-tracingPAX6

Identifiers

PMID30449321
PMCPMC6234918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.